Multiple Organ Failure: Clinical Trials

4 trials for Multiple Organ Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Unknown 4

Follow Multiple Organ Failure: new trials by email Literature Review of Multiple Organ Failure trials Research Report on Multiple Organ Failure

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
Initiation of vasopressine as a first vasoconstrictive drug, Initiation of noradrenaline as a first vasoconstrictive drug - Circulatory Shock
Phase 4UnknownUniversity of Thessaly1452023-12-152024-03-06
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Ulinastatin - Severe Sepsis, Septic Shock
Phase 4UnknownJinnah Postgraduate Medical Centre1752023-05-012023-06-08
The Pharmacokinetics of Fentanyl in Intensive Care Patients
Fentanyl - Multiple Organ Failure, Critical Care
Phase 4UnknownOslo University Hospital1502015-10-012015-10-29
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
6-methyl-prednisolone - Multiple Organ Dysfunction Syndrome
Phase 4UnknownHospital Universitario Principe de Asturias2402005-08-012008-05-13

Narrower conditions

Diabetes Insipidus (1)  ·  Sepsis (1)  ·  Shock (1)  ·  Shock, Septic (1)

Broader conditions

Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Shock (3)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pituitary Diseases (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Fentanyl (1)  ·  Norepinephrine (1)  ·  methyl 11,17,21-trihydroxy-3,20-dioxopregna-1,4-diene-16-carboxylate (1)  ·  urinastatin (1)

Sponsors

Hospital Universitario Principe de Asturias (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Oslo University Hospital (1)  ·  University of Thessaly (1)

Countries

Greece (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Miguel Sanchez, MD, PhD (1)  ·  Tom Heier, Professor (1)  ·  Zeeshan Ali, FCPS (1)

Results publications

PMID 12794416, PMID 18305265, PMID 27483065, PMID 28820036, PMID 29600824, PMID 34605781, PMID 36018257